Financing - February 12, 2024
“We see an increasing interest beyond oncology”
Nordic Life Science asked Ingrid Teigland Akay, Managing Partner, Hadean Ventures, about her predictions for 2024, including market trends, financing opportunities for SMEs and business strategy advice. What do you predict will be the dominant market trend within life sciences this year? “The life science industry is in many ways in a good position. There […]
Financing - February 12, 2024
“Early profitable companies are in the investor’s appetite”
Nordic Life Science asked Dan Akschuti, Equity Partner/Biotech Analyst, Pareto Securities, about his predictions for 2024, including market trends, financing opportunities for SMEs and business strategy advice. What do you predict will be the dominant market trend within life sciences this year? “Expected increased focus on late-stage (post phase 2) and commercial-stage companies while seeing […]
Business article - February 9, 2024
The Swedish government investigates new authority structure for funding of research & innovation
A recent government investigation proposes the establishment of three new funding agencies in Sweden, The Science Agency, The Strategic Research Agency and The Innovation Agency. At the same time, the current funding agencies, Formas, Forte, the Swedish Research Council, and Vinnova, are phased out, and the funding of research and innovation at the Swedish Energy […]
Biotech Business - February 7, 2024
Abera conducts a directed share issue of SEK 4 million
In connection with the company’s decision to develop a nasal vaccine candidate for influenza, based on recent progress with its mucosal vaccine platform, the board of Abera has decided to conduct a directed new share issue. Abera’s platform enables mucosal immunization, such as through nasal spray, which can inhibit the growth of viruses and bacteria […]
Biotech Business - January 25, 2024
Nykode has onboarded US based CapitalGroup as investors
In October 2023, Nykode completed a private placement round of approx NOK 505 million and this week, the company revealed that CapitalGroup, one of the world’s ten largest capital management funds, represented ca 40% of the financing round. This places CapitalGroup as the company’s sixth largest investor. Read more: Nykode Therapeutics raises NOK 505 million […]
Biotech Business - January 23, 2024
Xbrane announces a rights issue of units of approx SEK 343 million
The Board of Directors of Xbrane Biopharma has announced a rights issue of units of approximately SEK 343 million, consisting of shares and warrants of series TO1. Upon full exercise of the warrants of series TO1, Xbrane will receive approximately up to an additional SEK 78 million. The Rights Issue is conditional upon approval by […]
